scispace - formally typeset
H

Hamid Nasri

Researcher at Isfahan University of Medical Sciences

Publications -  413
Citations -  7393

Hamid Nasri is an academic researcher from Isfahan University of Medical Sciences. The author has contributed to research in topics: Hemodialysis & Nephrotoxicity. The author has an hindex of 39, co-authored 388 publications receiving 6596 citations. Previous affiliations of Hamid Nasri include Yahoo! & Shahrekord University of Medical Sciences.

Papers
More filters
Journal Article

Atherosclerosis: process, indicators, risk factors and new hopes.

TL;DR: The pathogenesis factors involved in Atherosclerosis have recently been cleared and the discovery of these factors has brought about new hopes for better prevention and treatment of atherosclerosis.
Journal Article

New concepts in nutraceuticals as alternative for pharmaceuticals.

TL;DR: In the present review, emphasis has been made to present herbal nutraceuticals effective on hard curative disorders related to oxidative stress including allergy, alzheimer, cardiovascular, cancer, diabetes, eye, immune, inflammatory and Parkinson's diseases as well as obesity.
Journal Article

Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants.

TL;DR: A list of medicinal plants that have been reported to be effective in hypertension is also presented in this paper, where the main focus is the main effect of antioxidants on hypertension and cardiovascular risk factors, however, antioxidant supplementation has not been shown consistently to be able to improve blood pressure after treatment with single or combination antioxidant therapy in subjects thought to be at high risk of cardiovascular disease.
Journal Article

Toxicity and safety of medicinal plants

TL;DR: Although medicinal plants are widely used and assumed to be safe, however, they can potentially be toxic especially in pregnancy, therefore, they should be administered by trained personnel.
Journal Article

Metformin: Current knowledge

TL;DR: The new implications of metformin are reviewed and the concerns in the use of met formin are discussed, referring to the recently published papers.